Glenmark Pharmaceuticals Ltd. India

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Glenmark Pharmaceuticals Ltd. India sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials none currently recruiting 8 completed later-stage tilt upper quartile by trial count

Glenmark Pharmaceuticals Ltd. India: 8 sponsored US clinical trials, none currently recruiting.

Glenmark Pharmaceuticals Ltd. India sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 7 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Osteoarthritis, with 1 trials.

Upper-quartile sponsor footprint

Glenmark Pharmaceuticals Ltd. India sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

How the Glenmark Pharmaceuticals Ltd. India archive is shaped

8 indexed studies, none listed as recruiting (0% open); 8 completed (100%).

Phase mix: 7 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Osteoarthritis (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Glenmark Pharmaceuticals Ltd. India: archived-pipeline peers nationwide

Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Glenmark Pharmaceuticals Ltd. India sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-07-11 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Glenmark Pharmaceuticals Ltd. IndiaAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10xBio22nd Century Group23andMe3-C Institute for Social Development
Glenmark Pharmaceuticals Ltd. India sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-07-11 snapshot).

Glenmark Pharmaceuticals Ltd. India sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Glenmark Pharmaceuticals Ltd. India page

8 registered trials is a research-attention snapshot, not an endorsement of Glenmark Pharmaceuticals Ltd. India or any single study.

  • None of Glenmark Pharmaceuticals Ltd. India's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Osteoarthritis is the condition Glenmark Pharmaceuticals Ltd. India studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Osteoarthritis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Glenmark Pharmaceuticals Ltd. India pipeline card: 8 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.